Temozolomide-induced aplastic anaemia: Case report and review of the literature

Aplastic Anemia

(2018) Neal S. Young   NEW ENGLAND JOURNAL OF MEDICINE

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

(2017) James R. Perry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temozolomide induced bone marrow Suppression-A single institution outcome analysis and review of the literature

(2015) Taxiarchis V. Kourelis et al.   AMERICAN JOURNAL OF HEMATOLOGY

Guidelines for the diagnosis and management of adult aplastic anaemia

(2015) Sally B. Killick et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epidemiologic and Molecular Prognostic Review of Glioblastoma

(2014) J. P. Thakkar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Temozolomide-Related Hematologic Toxicity

(2013) Claudia Scaringi et al.   ONKOLOGIE

Temozolomide-related idiosyncratic and other uncommon toxicities

(2012) Sanjay Dixit et al.   ANTI-CANCER DRUGS

Hematologic adverse events associated with temozolomide

(2011) J. Lee Villano et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A Rare Case of Aplastic Anemia Caused by Temozolomide

(2011) Benjamin J. George et al.   SOUTHERN MEDICAL JOURNAL

Temozolomide-induced severe myelosuppression

(2010) Robert K. Sylvester et al.   ANTI-CANCER DRUGS

Aplastic Anemia as a Cause of Death in a Patient with Glioblastoma Multiforme Treated with Temozolomide

(2010) Jindřich Kopecký et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Risk analysis of severe myelotoxicity with temozolomide: The effects of clinical and genetic factors

(2009) Terri S. Armstrong et al.   NEURO-ONCOLOGY

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY

Bone marrow transplantation for severe aplastic anemia secondary to temozolomide

(2008) E. Brannon Morris et al.   JOURNAL OF NEURO-ONCOLOGY